Literature DB >> 2896978

Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid.

W Vogel, H Kathrein, G Judmaier, H Braunsteiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2896978     DOI： 10.1016/s0140-6736(88)91974-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Ursodeoxycholic acid therapy in chronic active hepatitis.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  New directions in primary biliary cirrhosis.

Authors:  M C Bateson
Journal:  BMJ       Date:  1990-12-08

Review 3.  Current therapy of chronic liver disease.

Authors:  M W Stavinoha; R D Soloway
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 4.  Oral bile acids in cystic fibrosis-associated liver disease.

Authors:  C Colombo; A Crosignani; M G Apostolo; M T Marzano; N Bettinardi; A Giunta
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

Review 5.  Ursodeoxycholic acid in chronic liver disease.

Authors:  J S de Caestecker; R P Jazrawi; M L Petroni; T C Northfield
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

6.  Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.

Authors:  A Floreani; F Zappalà; M Mazzetto; R Naccarato; M Plebani; M Chiaramonte
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

Review 7.  Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.

Authors:  Francesca Saffioti; Kurinchi Selvan Gurusamy; Leonardo Henry Eusebi; Emmanuel Tsochatzis; Brian R Davidson; Douglas Thorburn
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.